Bharat Biotech's Covaxin likely to get clearance for phase 3 data from DCGI today: Sources

Bharat Biotech's Covaxin is likely to get clearance from Drugs Controller General of India (DCGI) today, sources said on Tuesday.

Read Also

Covaxin shows 77.8% efficacy in phase 3 trial data: Report